Characterization of Therapeutic Antibodies Derived from a Novel Yeast Expression Platform Using Bio-Layer Interferometry (BLI)
Leon Garcia-Martinez, Associate Director, Alder Biopharmaceuticals
Monoclonal antibodies have emerged as an important drug class. They provide both great specificity with low side effects and very fast development times. New technologies in the identification and production of monoclonal antibodies for therapeutic applications will be reviewed.